MDSCs significantly contribute to the suppressive microenvironment of tumors and are involved in tumor-related immune responses via a variety of chemokines (e.g., granulocyte-macrophage colony stimulating factor [GM-CSF]) that are involved in tumor-triggered endocrine signaling to the immune system [2,3]. This evidence concerns the gene CSF2 and neoplasm.